Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19
- PMID: 35329141
- PMCID: PMC8953719
- DOI: 10.3390/ijerph19063454
Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19
Abstract
Background: Lung cancer patients have the worst outcomes when affected by coronavirus disease 2019 (COVID-19). The molecular mechanisms underlying the association between lung cancer and COVID-19 remain unknown. The objective of this investigation was to determine whether there is crosstalk in molecular perturbation between COVID-19 and lung cancer, and to identify a molecular signature, molecular networks and signaling pathways shared by the two diseases.
Methods: We analyzed publicly available gene expression data from 52 severely affected COVID-19 human lung samples, 594 lung tumor samples and 54 normal disease-free lung samples. We performed network and pathways analysis to identify molecular networks and signaling pathways shared by the two diseases.
Results: The investigation revealed a signature of genes associated with both diseases and signatures of genes uniquely associated with each disease, confirming crosstalk in molecular perturbation between COVID-19 and lung cancer. In addition, the analysis revealed molecular networks and signaling pathways associated with both diseases.
Conclusions: The investigation revealed crosstalk in molecular perturbation between COVID-19 and lung cancer, and molecular networks and signaling pathways associated with the two diseases. Further research on a population impacted by both diseases is recommended to elucidate molecular drivers of the association between the two diseases.
Keywords: COVID-19; SARS-CoV-2; coronavirus; gene expression; lung cancer; networks; signaling pathways.
Conflict of interest statement
The authors declare no conflict of interest regarding the publication of this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures





Similar articles
-
Inferring pathway crosstalk networks using gene set co-expression signatures.Mol Biosyst. 2013 Jul;9(7):1822-8. doi: 10.1039/c3mb25506a. Epub 2013 Apr 17. Mol Biosyst. 2013. PMID: 23591523
-
Pathway crosstalk analysis of non-small cell lung cancer based on microarray gene expression profiling.Tumori. 2015 Jan-Feb;101(1):111-6. doi: 10.5301/tj.5000225. Epub 2015 Feb 11. Tumori. 2015. PMID: 25702679
-
COVID-19 Candidate Genes and Pathways Potentially Share the Association with Lung Cancer.Comb Chem High Throughput Screen. 2022;25(14):2463-2472. doi: 10.2174/1386207324666210712092649. Comb Chem High Throughput Screen. 2022. PMID: 34254909 Review.
-
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.Front Immunol. 2023 Mar 21;14:961642. doi: 10.3389/fimmu.2023.961642. eCollection 2023. Front Immunol. 2023. PMID: 37026010 Free PMC article.
-
Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.Front Immunol. 2021 Jul 23;12:694355. doi: 10.3389/fimmu.2021.694355. eCollection 2021. Front Immunol. 2021. PMID: 34367154 Free PMC article.
Cited by
-
In silico prediction of COVID-19 cytokine storm in lung cancer types.Biochem Biophys Rep. 2022 Dec;32:101350. doi: 10.1016/j.bbrep.2022.101350. Epub 2022 Sep 22. Biochem Biophys Rep. 2022. PMID: 36164562 Free PMC article.
References
-
- World Health Organization. [(accessed on 10 February 2022)]. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
-
- Centers for Disease Control and Prevention (CDC) [(accessed on 10 February 2022)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/index.html.
-
- Johns Hopkins University of Medicine (JHU) The Johns Hopkins 30-Minute COVID-19 Briefing: Expert Insights on What You Need to Know Now. [(accessed on 10 February 2022)]. Available online: https://coronavirus.jhu.edu/
-
- Flaherty G.T., Hession P., Liew C.H., Lim B.C.W., Leong T.K., Lim V., Sulaiman L.H. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: A critical literature review with clinical recommendations. Trop. Dis. Travel Med. Vaccines. 2020;6:1–13. doi: 10.1186/s40794-020-00118-y. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous